As shown inFigure 6B, after TFR1 overexpression, AML cells were treated with various concentrations of cytarabine (0, 0.25, 0.5, 1, 2, or 4 μM) for 24 h. The gene discussed is TFRC; the disease is acute myeloid leukemia.